Intrinsiqs

Is Bicara Therapeutics Inc. Common Stock overvalued?

Bicara Therapeutics Inc. Common Stock (BCAX) — key valuation metrics and fundamentals.

No verdict
Price
$18.99
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$1.25B
Dividend yield
0.0%
Return on equity
-41.5%
Sector
Healthcare

See the full interactive analysis →

Fair value compares BCAX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.